BOND VET SWOT ANALYSIS TEMPLATE RESEARCH Manufacturing & Industrials Competitive rivalry in the DXP

Competitive rivalry in the DXP market is fierce

contending with numerous rivals for player engagement and revenue

impacting Lens Protocol's competitive advantage

050 Luxury revenue share 18% Luxury unit share ~6% RevPAR YoY +18% Dynamic pricing lift +20% Luxury occupancy 68% FY2024 net loss $154

Impact: constrains premium pricing

BOND VET SWOT ANALYSIS TEMPLATE RESEARCH Manufacturing & Industrials Competitive rivalry in the DXPDive Deeper Into the Company's Strategic Blueprint Bond Vet shows clear strengths in brand trust and growing telehealth demand, but faces regulatory complexity and competitive pressure; our full SWOT unpacks these dynamics with financial context and strategic actions to help investors and operators decide next steps purchase the complete, editable report for a ready to use Word and Excel package. Strengths Network of over 55 clinics across 8 major US